Analysis of dose-volume histogram parameters for radiation pneumonitis after definitive concurrent chemoradiotherapy for esophageal cancer.
about
Relationship between radiation pneumonitis and organizing pneumonia after radiotherapy for breast cancerDosimetric factors and Lyman normal-tissue complication modelling analysis for predicting radiation-induced lung injury in postoperative breast cancer radiotherapy: a prospective study.Fan-shaped complete block on helical tomotherapy for esophageal cancer: a phantom studyPredictive factors for acute radiation pneumonitis in postoperative intensity modulated radiation therapy and volumetric modulated arc therapy of esophageal cancer.Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin-folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, randomized phase 2 trial.Impact of Neoadjuvant Chemoradiation on Short-Term Outcomes for Esophageal Squamous Cell Carcinoma Patients: A Meta-analysis.Associated factors of radiation pneumonitis induced by precise radiotherapy in 186 elderly patients with esophageal cancer.Predictive factors for radiation pneumonitis in oesophageal cancer patients treated with chemoradiotherapy without prophylactic nodal irradiation.[18F]-FDG uptake dose-response correlates with radiation pneumonitis in lung cancer patients.Dose-volume analysis for respiratory toxicity in intrathoracic esophageal cancer patients treated with definitive chemoradiotherapy using extended fields.Reduced lung dose during radiotherapy for thoracic esophageal carcinoma: VMAT combined with active breathing control for moderate DIBH.MMP-1 promoter polymorphism is associated with risk of radiation-induced lung injury in lung cancer patients treated with radiotherapy.Genetic variants in the plasminogen activator inhibitor-1 gene are associated with an increased risk of radiation pneumonitis in lung cancer patients.Mathematical Formulation of DMH-Based Inverse Optimization.Integral Dose-Based Inverse Optimization May Reduce Side Effects in Radiotherapy of Prostate Carcinoma.Risk of radiation pneumonitis in patients receiving taxane-based trimodality therapy for locally advanced esophageal cancer.Interobserver variability in radiation therapy plan output: Results of a single-institution study.Radiotherapy for esophageal cancer using simultaneous integrated boost techniques: dosimetric comparison of helical TomoTherapy, Volumetric-modulated Arc Therapy (RapidArc) and dynamic intensity-modulated radiotherapy.New Clinical Features and Dosimetric Predictor Identification for Symptomatic Radiation Pneumonitis after Tangential Irradiation in Breast Cancer Patients.Local field radiotherapy without elective nodal irradiation for postoperative loco-regional recurrence of esophageal cancer.Left-sided breast cancer loco-regional radiotherapy with deep inspiration breath-hold: Does volumetric-modulated arc radiotherapy reduce heart dose further compared with tangential intensity-modulated radiotherapy?Reduction in low-dose to normal tissue with the addition of deep inspiration breath hold (DIBH) to volumetric modulated arc therapy (VMAT) in breast cancer patients with implant reconstruction receiving regional nodal irradiation
P2860
Q21203114-F57FFA57-3489-4FEF-8ED7-0F8EEAED8792Q33779707-4DB13D51-BB4C-4E4A-8088-E5D394B4E786Q35125614-FDC308D2-35E7-48E4-8E42-F659ACC55B7DQ35663484-98EE40BC-8C8B-4ADF-BCAD-8D60D272CD8CQ36021874-72B21ACA-4DFE-47E0-8B95-87EB60E35410Q36045600-F339C35A-0439-4E48-862E-7558E6A06C92Q36318126-F49BA5C7-B0DA-4883-B61B-C1CE2FE37490Q36326303-9E4A67E7-F232-4A55-AD5A-AFCFA80C040AQ36766549-57150D6D-4C80-4751-8DB6-248D9B84D6F5Q37297253-57787B90-CA8A-4A8D-B5A9-9C510406892BQ37497033-53840E7C-BA8E-4519-A5C6-98B0C1A421C4Q37688507-20354B5C-BBA2-4E3A-A307-543FA532C93FQ37693331-653A1354-1860-4C23-BFF0-32D6FEF97025Q38283599-A941D697-1AEF-4C2D-B482-C9282DD7E78FQ38904590-0EB15E56-49CD-49E1-99C4-EA4B5D741743Q39880183-9ACB6250-1045-4CF3-BA14-CFAE5224D890Q42688881-1A85CB9F-FC9E-4EF8-9535-C73DCF612334Q45899297-A42DA6A5-69CF-4BA0-9CB4-C9EB01E6EF34Q47098103-1B249432-43FB-4975-8E91-52CE99C9144AQ50115856-3CC07526-8530-46A4-936E-C020A1661EF6Q51531448-50E0B048-B1EF-4D51-A7BD-7510E721418CQ58700854-8853F61E-FCE0-4FCD-978C-B9FB59FBB54C
P2860
Analysis of dose-volume histogram parameters for radiation pneumonitis after definitive concurrent chemoradiotherapy for esophageal cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Analysis of dose-volume histog ...... therapy for esophageal cancer.
@en
Analysis of dose-volume histog ...... therapy for esophageal cancer.
@nl
type
label
Analysis of dose-volume histog ...... therapy for esophageal cancer.
@en
Analysis of dose-volume histog ...... therapy for esophageal cancer.
@nl
prefLabel
Analysis of dose-volume histog ...... therapy for esophageal cancer.
@en
Analysis of dose-volume histog ...... therapy for esophageal cancer.
@nl
P2093
P1476
Analysis of dose-volume histog ...... otherapy for esophageal cancer
@en
P2093
Hideyuki Harada
Hirofumi Asakura
Hiroshi Fuji
Kazuhisa Furutani
Koichi Hirakawa
Narikazu Boku
Sadamoto Zenda
Shigeyuki Murayama
Shuichi Hironaka
Takayuki Hashimoto
P304
P356
10.1016/J.RADONC.2010.02.006
P577
2010-03-10T00:00:00Z